Evidence map›Paper›PMID 34272328›Full record

ArticleLife science alliance2021

Heterogeneous nuclear ribonucleoprotein E1 binds polycytosine DNA and monitors genome integrity.

Bidyut K Mohanty, Joseph Aq Karam, Breege V Howley, Annamarie C Dalton, Simon Grelet, Toros Dincman, William S Streitfeld, Je-Hyun Yoon, Lata Balakrishnan, Walter J Chazin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Bidyut K MohantyDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Joseph Aq KaramDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0002-4536-7362
Breege V HowleyDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Annamarie C DaltonDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Simon GreletDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Toros DincmanDivision of Hematology and Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0002-4449-0510
William S StreitfeldDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0003-2791-522X
Je-Hyun YoonDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Lata BalakrishnanDepartment of Biology, School of Science, Indiana University Purdue University Indianapolis, Indianapolis, IN, USA.
Walter J ChazinDepartments of Biochemistry and Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-2180-0790
David T LongDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0001-9232-0316
Philip H HoweDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA howep@musc.edu.ORCID 0000-0002-1358-1313
Medical University of South Carolina · USUniversity of Indianapolis · USVanderbilt University · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WALTER J. CHAZIN · 2001 to 2026
$89.6M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
TGF-regulated EMTR01CA154663 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Philip H Howe · 2011 to 2026
$5.1M
Structural Biology of Multi-Domain Proteins and Multi-Protein Machinery in DNA Replication and RepairR35GM118089 · NIGMS · VANDERBILT UNIVERSITY · PI WALTER J. CHAZIN · 2016 to 2026
$4.9M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR001451 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2015 to 2024
$4.6M
Connecting BRCA1 functions with DNA crosslink sensitivityR35GM119512 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LONG, DAVID THOMAS · 2016 to 2025
$3.9M
NCATS NIH HHS TL1 TR001451NCATS NIH HHS UL1 TR001450NCI NIH HHS P01 CA092584NCI NIH HHS R01 CA154663NIDDK NIH HHS P30 DK123704NIGMS NIH HHS R35 GM118089NIGMS NIH HHS R35 GM119512
6 · The paper itself

Abstract

Heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1) is a tumor suppressor protein that binds site- and structure-specifically to RNA sequences to regulate mRNA stability, facilitate alternative splicing, and suppress protein translation on several metastasis-associated mRNAs. Here, we show that hnRNP E1 binds polycytosine-rich DNA tracts present throughout the genome, including those at promoters of several oncogenes and telomeres and monitors genome integrity. It binds DNA in a site- and structure-specific manner. hnRNP E1-knockdown cells displayed increased DNA damage signals including γ-H2AX at its binding sites and also showed increased mutations. UV and hydroxyurea treatment of hnRNP E1-knockdown cells exacerbated the basal DNA damage signals with increased cell cycle arrest, activation of checkpoint proteins, and monoubiquitination of proliferating cell nuclear antigen despite no changes in deubiquitinating enzymes. DNA damage caused by genotoxin treatment localized to hnRNP E1 binding sites. Our work suggests that hnRNP E1 facilitates functions of DNA integrity proteins at polycytosine tracts and monitors DNA integrity at these sites.

Indexed as

Binding SitesGenomic InstabilityPoly CAnimalsBase SequenceDNADNA-Binding ProteinsDNA DamageHumansMiceModels, BiologicalMutationMutation RateNucleic Acid ConformationNucleotide MotifsProtein BindingDNADNA-Binding ProteinsPCBP1 protein, humanPoly Cpoly(dC)RNA-Binding Proteins

Identifiers

PMID34272328
PMCPMC8321654
OpenAlexW3177647959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.